Evidence map›Paper›PMID 28189554›Full record

ArticleUrology2017

The Influence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer in a Prospective, Population-based Cohort.

Maximilian F Lang, Mark D Tyson, JoAnn Rudd Alvarez, Tatsuki Koyama, Karen E Hoffman, Matthew J Resnick, Matthew R Cooperberg, Xiao-Cheng Wu, Vivien Chen, Lisa E Paddock and 8 more

Abstract read
In one paragraph

Article in Urology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 1 country.

Maximilian F LangVanderbilt University School of Medicine, Nashville, TN. Electronic address: maximilian.f.lang@vanderbilt.edu.
Mark D TysonDepartment of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN.
JoAnn Rudd AlvarezDepartment of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN.
Tatsuki KoyamaDepartment of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN.
Karen E HoffmanDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Matthew J ResnickDepartment of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN; Department of Health Policy, Vanderbilt University School of Medicine, Nashville, TN; The Geriatric Research, Education, and Clinical Center, Tennessee Valley Veterans Affairs Health Care System, Nashville, TN.
Matthew R CooperbergDepartment of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA; Epidemiology and Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA.
Xiao-Cheng WuSchool of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA.
Vivien ChenSchool of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA.
Lisa E PaddockRutgers Cancer Institute of New Jersey, Cancer Surveillance Research Program, New Brunswick, NJ.
Ann S HamiltonDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Mia HashibeDepartment of Family and Preventive Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
Michael GoodmanDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.
Sheldon GreenfieldCenter for Health Policy Research and Department of Medicine, University of California Irvine, Irvine, CA.
Sherrie H KaplanHealth Policy Research Institute, University of California Irvine, Irvine, CA.
Antoinette StroupRutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ.
David F PensonDepartment of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN; The Geriatric Research, Education, and Clinical Center, Tennessee Valley Veterans Affairs Health Care System, Nashville, TN.
Daniel A BarocasDepartment of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN.
Vanderbilt University · USLouisiana State University Health Sciences Center New Orleans · USRutgers, The State University of New Jersey · USUniversity of California, Irvine · USVanderbilt University Medical Center · USEmory University · USThe University of Texas MD Anderson Cancer Center · USUniversity of California, San Francisco · USUniversity of Southern California · USUniversity of Utah · USVA Tennessee Valley Healthcare System · US

Funding

Comparative Effectiveness of Treatments for Localized Prostate CancerR01HS019356 · AHRQ · VANDERBILT UNIVERSITY · PI PENSON, DAVID F. · 2010 to 2010
$7.6M
Surgical Oncology Training GrantT32CA106183 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI James Richard Goldenring · 2004 to 2026
$6.0M
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01PC067009 · PC · FRED HUTCHINSON CANCER RESEARCH CENTER · PI THOMAS, DAVID B · 1996 to 2000
$3.0M
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01PC067010 · PC · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROSS, RONALD K · 1996 to 2000
$2.4M
Comparative Effectiveness of Modern Therapies for Localized Prostate CancerR01HS022640 · AHRQ · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PENSON, DAVID F. · 2013 to 2013
$1.8M
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01PC067006 · PC · EMORY UNIVERSITY · PI YOUNG, JOHN L · 1996 to 2000
$1.7M
Race, Comorbidity & Long Term Prostate Cancer OutcomesR01CA114524 · NCI · VANDERBILT UNIVERSITY · PI PENSON, DAVID F. · 2007 to 2009
$1.7M
Trends in Surveillance for Localized Prostate Cancer and Barriers to its UseR03CA173812 · NCI · VANDERBILT UNIVERSITY · PI BAROCAS, DANIEL A · 2013 to 2014
$154k
AHRQ HHS R01 HS019356AHRQ HHS R01 HS022640NCI NIH HHS N01 PC067006NCI NIH HHS N01 PC067009NCI NIH HHS N01 PC067010NCI NIH HHS R01 CA114524NCI NIH HHS R03 CA173812NCI NIH HHS T32 CA106183
6 · The paper itself

Abstract

objectiveTo evaluate the influence of psychosocial factors such as prostate cancer (PCa) anxiety, social support, participation in medical decision-making (PDM), and educational level on patient decisions to discontinue PCa active surveillance (AS) in the absence of disease progression.

methodsThe Comparative Effectiveness Analysis of Surgery and Radiation study is a prospective, population-based cohort study of men with localized PCa diagnosed in 2011-2012. PCa anxiety, social support, PDM, educational level, and patient reasons for discontinuing AS were assessed through patient surveys. A Cox proportional hazards model examined the relationship between psychosocial variables and time to discontinuation of AS.

resultsOf 531 patients on AS, 165 (30.9%) underwent treatment after median follow-up of 37 months. Whereas 69% of patients cited only medical reasons for discontinuing AS, 31% cited at least 1 personal reason, and 8% cited personal reasons only. Patients with some college education discontinued AS significantly earlier (hazard ratio: 2.0, 95% confidence interval: 1.2, 3.2) than patients with less education. PCa anxiety, social support, and PDM were not associated with seeking treatment.

conclusionWe found that 31% of men who choose AS for PCa discontinue AS within 3 years. Eight percent of men who sought treatment did so in the absence of disease progression. Education, but not psychosocial factors, seems to influence definitive treatment-seeking. Future research is needed to understand how factors unrelated to disease severity influence treatment decisions among patients on AS to identify opportunities to improve adherence to AS.

Indexed as

Decision MakingProstatic NeoplasmsSentinel SurveillanceSocial SupportAgedAnxietyEducational StatusHumansMaleMiddle AgedNeoplasm GradingNeoplasm StagingProportional Hazards ModelsPsychologyRisk AssessmentUnited States

Identifiers

PMID28189554
PMCPMC5410889
OpenAlexW2586632559

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.